Instem plc: Earn Outs and Deferred Payments - Revision history

Manos at 13:51, 3 September 2022

2022-09-03T13:51:06Z

← Older revision		Revision as of 14:51, 3 September 2022
Line 1:		Line 1:
			{{Cover Image\|[[File:Instem plc update cover image 3.jpg]]}}

	== Summary ==		== Summary ==
	Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, is pleased to announce that the first tranches of the agreed earn-out and deferred payments in respect of the acquisition of the entire share capital of d-Wise Technologies, Inc ("d-wise") and d-wise's subsidiaries, which completed on 1st April 2021, have now been made.		Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, is pleased to announce that the first tranches of the agreed earn-out and deferred payments in respect of the acquisition of the entire share capital of d-Wise Technologies, Inc ("d-wise") and d-wise's subsidiaries, which completed on 1st April 2021, have now been made.

94.119.64.73 at 15:25, 2 September 2022

2022-09-02T15:25:55Z

← Older revision		Revision as of 16:25, 2 September 2022
Line 1:		Line 1:
	Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, is pleased to announce that the first tranches of the agreed earn out and deferred payments in respect of the acquisition of the entire share capital of d-Wise Technologies, Inc ("d-wise") and d-wise's subsidiaries, which completed on 1 April 2021, have now been made.		== Summary ==
			Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, is pleased to announce that the first tranches of the agreed earn-out and deferred payments in respect of the acquisition of the entire share capital of d-Wise Technologies, Inc ("d-wise") and d-wise's subsidiaries, which completed on 1st April 2021, have now been made.

	As a result of d-wise achieving its earn out targets in the financial year ended 31 December 2021, Instem has paid the initial earn out consideration of $1.5m in ordinary shares of 10 pence each in Instem ("Ordinary Shares") ("Initial Earn Out Consideration").		As a result of d-wise achieving its earn out targets in the financial year ended 31st December 2021, Instem has paid the initial earn-out consideration of $1.5m in ordinary shares of 10 pence each in Instem ("Ordinary Shares") ("Initial Earn Out Consideration").

	The Company has also paid the first tranche of the deferred consideration (due to certain vendors in d-wise) comprising $3,191,775 in cash and $1,042,604 in Ordinary Shares which was payable on the 12-month anniversary of completion ("Deferred Consideration").		The Company has also paid the first tranche of the deferred consideration (due to certain vendors in d-wise) comprising $3,191,775 in cash and $1,042,604 in Ordinary Shares which was payable on the 12-month anniversary of completion ("Deferred Consideration").
Line 9:		Line 10:
	Separately, the Company is also pleased to announce that the full £2.0m earn out has been achieved in respect of the acquisition of the entire share capital of The Edge Software Consultancy Ltd ("The Edge"), which completed on 1 March 2021. As a result of The Edge achieving its earn out targets in the twelve month period post-completion, £1.0m will be paid in cash to the vendors of The Edge by 31 May 2022, with a further £1.0m to be paid in cash on or before 1 March 2023. In addition the £0.5m deferred consideration was paid at the end of February 2022.		Separately, the Company is also pleased to announce that the full £2.0m earn out has been achieved in respect of the acquisition of the entire share capital of The Edge Software Consultancy Ltd ("The Edge"), which completed on 1 March 2021. As a result of The Edge achieving its earn out targets in the twelve month period post-completion, £1.0m will be paid in cash to the vendors of The Edge by 31 May 2022, with a further £1.0m to be paid in cash on or before 1 March 2023. In addition the £0.5m deferred consideration was paid at the end of February 2022.

	Issue of Equity and Admission		== Issue of Equity and Admission ==

	As a result, 176,124 Ordinary Shares have been issued in respect of the Initial Earn Out Consideration at an issue price 650p per Ordinary Share, calculated at the average middle market closing price over the five business days immediately preceding but excluding 30 March 2022.		As a result, 176,124 Ordinary Shares have been issued in respect of the Initial Earn Out Consideration at an issue price 650p per Ordinary Share, calculated at the average middle market closing price over the five business days immediately preceding but excluding 30 March 2022.

Line 17:		Line 17:
	Application has been made to the London Stock Exchange for a total of 296,952 new Ordinary Shares to be admitted to trading on AIM ("New Ordinary Shares"). Admission of the New Ordinary Shares is expected to take place at 8.00 a.m. on 29 April 2022.		Application has been made to the London Stock Exchange for a total of 296,952 new Ordinary Shares to be admitted to trading on AIM ("New Ordinary Shares"). Admission of the New Ordinary Shares is expected to take place at 8.00 a.m. on 29 April 2022.

	Lock-ins		== Lock-ins ==

	Of the 296,952 New Ordinary Shares issued in total to the d-wise vendors in connection with the Initial Earn Out Consideration and Deferred Consideration, 199,101 New Ordinary Shares will remain subject to lock-ins until 07 June 2022 and 164,972 New Ordinary Shares will remain subject to lock-ins until 20 March 2023. This means that, also taking into account Ordinary Shares that were issued at completion of the acquisition and that remain subject to lock-ins, a total of 781,214 Ordinary Shares will remain subject to lock-ins until 07 June 2022 and 647,294 Ordinary Shares will remain subject to lock-ins until 20 March 2023.		Of the 296,952 New Ordinary Shares issued in total to the d-wise vendors in connection with the Initial Earn Out Consideration and Deferred Consideration, 199,101 New Ordinary Shares will remain subject to lock-ins until 07 June 2022 and 164,972 New Ordinary Shares will remain subject to lock-ins until 20 March 2023. This means that, also taking into account Ordinary Shares that were issued at completion of the acquisition and that remain subject to lock-ins, a total of 781,214 Ordinary Shares will remain subject to lock-ins until 07 June 2022 and 647,294 Ordinary Shares will remain subject to lock-ins until 20 March 2023.

	Total Voting Rights		== Total Voting Rights ==

	Following the issue and allotment of the New Ordinary Shares, the Company's issued share capital comprises 22,676,808 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company is 22,676,808.		Following the issue and allotment of the New Ordinary Shares, the Company's issued share capital comprises 22,676,808 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company is 22,676,808.

Line 31:		Line 29:

	== Additional information ==		== Additional information ==
	Which is the main investment that this report is about? [[Main investment::Instem plc]]		Which is the main investment that this report is about? [[Main investment::Instem plc]].
	[[Category:Update]]		[[Category:Update]]
	[[Category:Instem plc]]		[[Category:Instem plc]]
	__INDEX__		__INDEX__

94.119.64.34: Created page with "Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, is pleased to announce that the first tranches of the agreed earn out and deferred payments in respect of the acquisition of the entire share capital of d-Wise Technologies, Inc ("d-wise") and d-wise's subsidiaries, which completed on 1 April 2021, have now been made. As a result of d-wise achieving its earn out targets in the financial year ended 31 December 2021, Instem has p..."

2022-09-02T15:24:08Z

Created page with "Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, is pleased to announce that the first tranches of the agreed earn out and deferred payments in respect of the acquisition of the entire share capital of d-Wise Technologies, Inc ("d-wise") and d-wise's subsidiaries, which completed on 1 April 2021, have now been made. As a result of d-wise achieving its earn out targets in the financial year ended 31 December 2021, Instem has p..."

New page

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, is pleased to announce that the first tranches of the agreed earn out and deferred payments in respect of the acquisition of the entire share capital of d-Wise Technologies, Inc ("d-wise") and d-wise's subsidiaries, which completed on 1 April 2021, have now been made.

As a result of d-wise achieving its earn out targets in the financial year ended 31 December 2021, Instem has paid the initial earn out consideration of $1.5m in ordinary shares of 10 pence each in Instem ("Ordinary Shares") ("Initial Earn Out Consideration").

The Company has also paid the first tranche of the deferred consideration (due to certain vendors in d-wise) comprising $3,191,775 in cash and $1,042,604 in Ordinary Shares which was payable on the 12-month anniversary of completion ("Deferred Consideration").

Instem, through its subsidiary Instem Inc., acquired d-wise for an initial consideration of $20m in cash and shares, subject to an adjustment mechanism plus any deferred consideration and any earn out payable under the terms of the share purchase agreement. Following payment of the Initial Earn Out Consideration, a further earn out consideration of $1.5m remains payable in cash on the 24-month anniversary of completion of the acquisition. Additionally, the second tranche of the deferred consideration, comprising $4m plus interest in cash, will be payable on the 24-month anniversary of completion.

Separately, the Company is also pleased to announce that the full £2.0m earn out has been achieved in respect of the acquisition of the entire share capital of The Edge Software Consultancy Ltd ("The Edge"), which completed on 1 March 2021. As a result of The Edge achieving its earn out targets in the twelve month period post-completion, £1.0m will be paid in cash to the vendors of The Edge by 31 May 2022, with a further £1.0m to be paid in cash on or before 1 March 2023. In addition the £0.5m deferred consideration was paid at the end of February 2022.

Issue of Equity and Admission

As a result, 176,124 Ordinary Shares have been issued in respect of the Initial Earn Out Consideration at an issue price 650p per Ordinary Share, calculated at the average middle market closing price over the five business days immediately preceding but excluding 30 March 2022.

In addition, 120,828 Ordinary Shares have been issued in respect of the Deferred Consideration and have been issued at a price 657p per Ordinary Share, calculated at the average middle market closing price over the five business days immediately preceding but excluding 31 March 2022.

Application has been made to the London Stock Exchange for a total of 296,952 new Ordinary Shares to be admitted to trading on AIM ("New Ordinary Shares"). Admission of the New Ordinary Shares is expected to take place at 8.00 a.m. on 29 April 2022.

Lock-ins

Of the 296,952 New Ordinary Shares issued in total to the d-wise vendors in connection with the Initial Earn Out Consideration and Deferred Consideration, 199,101 New Ordinary Shares will remain subject to lock-ins until 07 June 2022 and 164,972 New Ordinary Shares will remain subject to lock-ins until 20 March 2023. This means that, also taking into account Ordinary Shares that were issued at completion of the acquisition and that remain subject to lock-ins, a total of 781,214 Ordinary Shares will remain subject to lock-ins until 07 June 2022 and 647,294 Ordinary Shares will remain subject to lock-ins until 20 March 2023.

Total Voting Rights

Following the issue and allotment of the New Ordinary Shares, the Company's issued share capital comprises 22,676,808 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company is 22,676,808.

The figure of 22,676,808 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure and Transparency Rules.

== Source(s) ==
[https://www.investegate.co.uk/instem-plc--ins-/rns/earn-outs-and-deferred-payments/202204261015273704J/ "Earn Outs and Deferred Payments]" — Instem plc, 26th April 2022.

== Additional information ==
Which is the main investment that this report is about? [[Main investment::Instem plc]]
[[Category:Update]]
[[Category:Instem plc]]
__INDEX__